» Authors » Maarten J Boom

Maarten J Boom

Explore the profile of Maarten J Boom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 74
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Gardenbroek T, Pinkney T, Sahami S, Morton D, Buskens C, Ponsioen C, et al.
BMC Surg . 2015 Apr; 15:30. PMID: 25887789
Background: Over the past 20 years evidence has accumulated confirming the immunomodulatory role of the appendix in ulcerative colitis (UC). This led to the idea that appendectomy might alter the...
3.
Swank H, Vermeulen J, Lange J, M Mulder I, van der Hoeven J, Stassen L, et al.
BMC Surg . 2010 Oct; 10:29. PMID: 20955571
Background: Recently, excellent results are reported on laparoscopic lavage in patients with purulent perforated diverticulitis as an alternative for sigmoidectomy and ostomy.The objective of this study is to determine whether...
4.
Kruijer M, Groh O, de Bruine J, Boom M, Verbeek P
Ned Tijdschr Geneeskd . 2010 Aug; 154:A1796. PMID: 20719014
An 18-year-old male presented at the casualty department with acute right upper abdominal pain. Laboratory examinations showed no abnormalities apart from a mildly elevated leukocyte count. Ultrasound examination revealed hydrops...
5.
van den Broek F, de Graaf E, Dijkgraaf M, Reitsma J, Haringsma J, Timmer R, et al.
BMC Surg . 2009 Mar; 9:4. PMID: 19284647
Background: Recent non-randomized studies suggest that extended endoscopic mucosal resection (EMR) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM). If equally effective, EMR might be...
6.
Eshuis E, Bemelman W, van Bodegraven A, Sprangers M, Bossuyt P, van Milligen de Wit A, et al.
BMC Surg . 2008 Aug; 8:15. PMID: 18721465
Background: With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is generally treated with infliximab. Infliximab is...